Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Edwards

Showing results (541-550 of 741) with videos related to

Pageof 75
Sort By:
Environmental Health Perspectives|May 16, 2015
A Workflow to Investigate Exposure and Pharmacokinetic Influences on High-Throughput in Vitro Chemical Screening Based on Adverse Outcome PathwaysMartin B Phillips, Jeremy A Leonard, Christopher M Grulke, et al.
Archives of Neurology|September 15, 2004
Botulinum toxin type A for treating voice tremorCharles H Adler, Stephen F Bansberg, Joseph G Hentz, et al.
Molecular and Cellular Endocrinology|May 12, 2004
The use of scanning ion conductance microscopy to image A6 cellsJulia Gorelik, Yanjun Zhang, Andrew I Shevchuk, et al.
Journal of Autoimmunity|December 25, 2013
The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentG Cambridge, H C Perry, L Nogueira, et al.
Gastroenterology|October 9, 2007
Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's diseaseChiedzo M Mpofu, Barry J Campbell, Sreedhar Subramanian, et al.
Computational Toxicology (Amsterdam, Netherlands)|February 13, 2023
A Mechanistic Framework for Integrating Chemical Structure and High-Throughput Screening Results to Improve Toxicity PredictionsMark D Nelms, Claire L Mellor, Steven J Enoch, et al.
The Lancet. Neurology|October 22, 2005
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trialAndrew L Lux, Stuart W Edwards, Eleanor Hancock, et al.
Lancet (London, England)|November 16, 2004
The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trialAndrew L Lux, Stuart W Edwards, Eleanor Hancock, et al.
Epilepsia|August 24, 2010
The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classificationJohn P Osborne, Andrew L Lux, Stuart W Edwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocolJ E Radford, C P Burns, M P Jones, et al.
Pageof 75

Showing results (541-550 of 741) with videos related to

Sort By:
Pageof 75
Environmental Health Perspectives|May 16, 2015
A Workflow to Investigate Exposure and Pharmacokinetic Influences on High-Throughput in Vitro Chemical Screening Based on Adverse Outcome PathwaysMartin B Phillips, Jeremy A Leonard, Christopher M Grulke, et al.
Archives of Neurology|September 15, 2004
Botulinum toxin type A for treating voice tremorCharles H Adler, Stephen F Bansberg, Joseph G Hentz, et al.
Molecular and Cellular Endocrinology|May 12, 2004
The use of scanning ion conductance microscopy to image A6 cellsJulia Gorelik, Yanjun Zhang, Andrew I Shevchuk, et al.
Journal of Autoimmunity|December 25, 2013
The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentG Cambridge, H C Perry, L Nogueira, et al.
Gastroenterology|October 9, 2007
Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's diseaseChiedzo M Mpofu, Barry J Campbell, Sreedhar Subramanian, et al.
Computational Toxicology (Amsterdam, Netherlands)|February 13, 2023
A Mechanistic Framework for Integrating Chemical Structure and High-Throughput Screening Results to Improve Toxicity PredictionsMark D Nelms, Claire L Mellor, Steven J Enoch, et al.
The Lancet. Neurology|October 22, 2005
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trialAndrew L Lux, Stuart W Edwards, Eleanor Hancock, et al.
Lancet (London, England)|November 16, 2004
The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trialAndrew L Lux, Stuart W Edwards, Eleanor Hancock, et al.
Epilepsia|August 24, 2010
The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classificationJohn P Osborne, Andrew L Lux, Stuart W Edwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocolJ E Radford, C P Burns, M P Jones, et al.
Pageof 75